Published in Lancet on June 11, 2011
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med (2013) 3.15
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS (2013) 2.66
A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc (2013) 2.54
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res (2011) 2.45
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
A strategic revolution in HIV and global health. Lancet (2011) 2.21
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS (2013) 2.17
The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med (2013) 1.98
In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) (2012) 1.84
Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr (2012) 1.78
The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved (2013) 1.75
From personal survival to public health: community leadership by men who have sex with men in the response to HIV. Lancet (2012) 1.75
Social capital and HIV competent communities: the role of community groups in managing HIV/AIDS in rural Zimbabwe. AIDS Care (2013) 1.73
Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting. PLoS One (2016) 1.68
Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography. PLoS One (2016) 1.62
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. PLoS Med (2012) 1.62
Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0. PLoS One (2016) 1.61
What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One (2016) 1.59
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS (2012) 1.55
HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med (2012) 1.55
Economics of antiretroviral treatment vs. circumcision for HIV prevention. Proc Natl Acad Sci U S A (2012) 1.54
Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect (2012) 1.48
Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS (2012) 1.47
HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med (2012) 1.45
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Editorial: Global action to reduce HIV stigma and discrimination. J Int AIDS Soc (2013) 1.36
The next generation of the World Health Organization's global antiretroviral guidance. J Int AIDS Soc (2013) 1.34
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions. PLoS Med (2012) 1.29
Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One (2013) 1.26
HIV epidemic appraisals for assisting in the design of effective prevention programmes: shifting the paradigm back to basics. PLoS One (2012) 1.25
How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV. PLoS One (2014) 1.20
Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries. Bull World Health Organ (2014) 1.19
Redesigning the AIDS response for long-term impact. Bull World Health Organ (2011) 1.17
Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence. Proc Natl Acad Sci U S A (2014) 1.13
Priorities for developing countries in the global response to non-communicable diseases. Global Health (2012) 1.13
Effective HIV prevention: the indispensable role of social science. J Int AIDS Soc (2012) 1.12
Access to Basic HIV-Related Services and PrEP Acceptability among Men Who Have sex with Men Worldwide: Barriers, Facilitators, and Implications for Combination Prevention. J Sex Transm Dis (2013) 1.10
Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries. PLoS One (2016) 1.10
Creative Contributory Contests to Spur Innovation in Sexual Health: 2 Cases and a Guide for Implementation. Sex Transm Dis (2015) 1.09
Articulating a rights-based approach to HIV treatment and prevention interventions. Curr HIV Res (2011) 1.08
"You are wasting our drugs": health service barriers to HIV treatment for sex workers in Zimbabwe. BMC Public Health (2013) 1.06
The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review. J Int AIDS Soc (2014) 1.06
Evaluating the effects of community-based organization engagement on HIV and AIDS-related risk behavior in Kenya. AIDS Care (2013) 1.04
Action on noncommunicable diseases: balancing priorities for prevention and care. Bull World Health Organ (2011) 1.03
Cost drivers for voluntary medical male circumcision using primary source data from sub-Saharan Africa. PLoS One (2014) 1.02
Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study. BMJ Open (2012) 1.01
Comparison of mobile apps for the leading causes of death among different income zones: a review of the literature and app stores. JMIR Mhealth Uhealth (2014) 1.00
Conceptualizing community mobilization for HIV prevention: implications for HIV prevention programming in the African context. PLoS One (2013) 1.00
Between individual agency and structure in HIV prevention: understanding the middle ground of social practice. Am J Public Health (2013) 0.99
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med (2012) 0.99
Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward. AIDS Patient Care STDS (2015) 0.99
Modelling the impact of antiretroviral therapy on the epidemic of HIV. Curr HIV Res (2011) 0.98
Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr (2014) 0.97
It takes a village: community-based organizations and the availability and utilization of HIV/AIDS-related services in Nigeria. AIDS Care (2013) 0.96
Grassroots community organizations' contribution to the scale-up of HIV testing and counselling services in Zimbabwe. AIDS (2013) 0.96
The impact of community mobilisation on HIV prevention in middle and low income countries: a systematic review and critique. AIDS Behav (2014) 0.95
Financing essential HIV services: a new economic agenda. PLoS Med (2013) 0.95
Is endemic political corruption hampering provision of ART and PMTCT in developing countries? J Int AIDS Soc (2014) 0.95
Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open (2016) 0.94
Community mobilization and empowerment of female sex workers in Karnataka State, South India: associations with HIV and sexually transmitted infection risk. Am J Public Health (2014) 0.92
Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenya. AIDS Res Treat (2012) 0.92
Financing HIV programming: how much should low- and middle-income countries and their donors pay? PLoS One (2013) 0.92
The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020. PLoS Med (2015) 0.90
Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis. PLoS Med (2016) 0.90
The Global Fund's resource allocation decisions for HIV programmes: addressing those in need. J Int AIDS Soc (2011) 0.90
Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs. Curr HIV Res (2015) 0.90
Addressing gender inequality and intimate partner violence as critical barriers to an effective HIV response in sub-Saharan Africa. J Int AIDS Soc (2014) 0.90
Public health: Towards a cure for HIV. Nature (2012) 0.89
The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in India. PLoS One (2014) 0.89
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health (2013) 0.87
HIV and AIDS Data Hub for Asia Pacific: a regional tool to support strategic information needs. Western Pac Surveill Response J (2012) 0.87
Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries. Health Econ (2016) 0.87
A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis. Health Res Policy Syst (2014) 0.87
Why increasing availability of ART is not enough: a rapid, community-based study on how HIV-related stigma impacts engagement to care in rural South Africa. BMC Public Health (2016) 0.87
Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV. PLoS Med (2013) 0.86
Expanding the role of community mobilization to accelerate progress towards ending vertical transmission of HIV in Uganda: the Networks model. J Int AIDS Soc (2012) 0.86
A public health approach to hepatitis C control in low- and middle-income countries. PLoS Med (2015) 0.85
Where will the money come from? Alternative mechanisms to HIV donor funding. BMC Public Health (2014) 0.85
The impact of social services interventions in developing countries: a review of the evidence of impact on clinical outcomes in people living with HIV. J Acquir Immune Defic Syndr (2015) 0.85
Investigating combination HIV prevention: isolated interventions or complex system. J Int AIDS Soc (2015) 0.85
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res (2011) 0.84
Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries. BMC Public Health (2012) 0.84
Total HIV/AIDS expenditures in Dehong Prefecture, Yunnan province in 2010: the first systematic evaluation of both health and non-health related HIV/AIDS expenditures in China. PLoS One (2013) 0.83
Children's role in the community response to HIV in Zimbabwe. J Int AIDS Soc (2013) 0.83
Personalized Biobehavioral HIV Prevention for Women and Adolescent Girls. Glob Adv Health Med (2013) 0.83
What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India. Health Econ (2016) 0.83
Funding and expenditure of a sample of community-based organizations in Kenya, Nigeria, and Zimbabwe. AIDS Care (2013) 0.83
Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods. BMC Health Serv Res (2014) 0.83
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda. BMC Public Health (2012) 0.83
A qualitative analysis of the barriers and facilitators of HIV counselling and testing perceived by adolescents in South Africa. BMC Health Serv Res (2015) 0.83
Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations. J Int AIDS Soc (2014) 0.81
Community mobilisation and empowerment interventions as part of HIV prevention for female sex workers in Southern India: a cost-effectiveness analysis. PLoS One (2014) 0.81
Second generation HIV surveillance in Pakistan: policy challenges and opportunities. Sex Transm Infect (2012) 0.81
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
An assessment of interactions between global health initiatives and country health systems. Lancet (2009) 10.53
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73
Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS (2011) 6.26
Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001. AIDS (2003) 5.88
Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. Int J Drug Policy (2012) 5.68
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med (2006) 5.62
UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis (2012) 5.42
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS (2006) 5.31
Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet (2002) 5.21
Hormonal contraception and the risk of HIV acquisition. AIDS (2007) 5.05
Technologies for global health. Lancet (2012) 5.05
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA (2005) 4.32
HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet (2003) 3.85
Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments. Lancet (2010) 3.73
Next steps for research on hormonal contraception and HIV. Lancet (2013) 3.70
Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev (2012) 3.70
Universal access to malaria medicines: innovation in financing and delivery. Lancet (2010) 3.31
Coming to terms with complexity: a call to action for HIV prevention. Lancet (2008) 3.15
Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. Sex Transm Infect (2010) 3.14
The real challenges for scaling up ART in sub-Saharan Africa. AIDS (2006) 3.02
Child mortality and HIV infection in Africa: a review. AIDS (2004) 3.02
Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998. AIDS (2002) 2.97
AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS (2009) 2.92
The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One (2012) 2.88
Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev (2012) 2.87
HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis (2006) 2.82
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76
HIV infection does not disproportionately affect the poorer in sub-Saharan Africa. AIDS (2007) 2.67
The India HPV-vaccine suspension. Lancet (2010) 2.65
Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis (2012) 2.62
Improving facility-based care for sick children in Uganda: training is not enough. Health Policy Plan (2005) 2.61
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res (2011) 2.45
Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol (2003) 2.45
Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ (2005) 2.44
Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev (2013) 2.42
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41
Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One (2010) 2.30
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Making HIV prevention programmes work. Lancet (2008) 2.22
Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet (2004) 2.20
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Mobile phone messaging for preventive health care. Cochrane Database Syst Rev (2012) 2.15
Combination HIV prevention. Lancet (2008) 2.10
GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. Clin Infect Dis (2004) 2.08
Back to basics in HIV prevention: focus on exposure. BMJ (2003) 1.99
Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk? Am J Trop Med Hyg (2004) 1.98
Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One (2011) 1.98
The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One (2009) 1.97
What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect (2010) 1.92
Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward. J HIV AIDS Surveill Epidemiol (2010) 1.90
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89
Funding for malaria control 2006-2010: a comprehensive global assessment. Malar J (2012) 1.87
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS (2013) 1.81
Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development. PLoS Med (2012) 1.81
Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr (2012) 1.78
The epidemiology of HIV infection among young people aged 15-24 years in southern Africa. AIDS (2008) 1.77
Improving quality and efficiency of facility-based child health care through Integrated Management of Childhood Illness in Tanzania. Health Policy Plan (2005) 1.77
HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis (2006) 1.75
Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis (2009) 1.73
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72
Social, economic, human rights and political challenges to global mental health. Ment Health Fam Med (2011) 1.72
Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi. PLoS One (2013) 1.70
Improved estimates of India's HIV burden in 2006. Indian J Med Res (2009) 1.70
Market failure and the poverty of new drugs in maternal health. PLoS Med (2008) 1.70
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Guidance for evidence-informed policies about health systems: linking guidance development to policy development. PLoS Med (2012) 1.68
Prevalence of HIV among truck drivers visiting sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis (2002) 1.66
Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health (2012) 1.66
Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ (2012) 1.64
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS (2009) 1.60
Global health initiative investments and health systems strengthening: a content analysis of global fund investments. Global Health (2013) 1.60
Estimates of HIV incidence from household-based prevalence surveys. AIDS (2010) 1.59